Skip to main content
. 2011 Aug 29;52(9):6898–6910. doi: 10.1167/iovs.11-7701

Table 1.

Clinical and Molecular Characteristics of the CRB1 Patients

Patient Age at First Visit (y/Sex) CRB1 Mutation
Visual Acuity* Refraction Fundus Features Kinetic Visual Field Extent (V-4e)§ ERG Amplitude
Reference
Allele 1 Allele 2 Rod b-Wave Cone Flicker
P1 0.6/F p.Cys948Tyr Deletion of CRB1 F&FL +6.50 Granular NP ND 11 4, 5, 7
P2 4/M p.Cys948Tyr p.Ser1350 del1 20/100 +6.00 Granular 7 ND ND 4, 5, 7, 45
P3 5/F p.Glu204 del7 p.Cys480Arg 20/200 +6.50 Granular; white dots NP ND 10 7
P4 8/F p.Cys948Tyr p.Cys1218Phe 20/30 +5.50 Granular; PPRPE 30 ND 7 4, 5, 7, 45
P5 9/F p.Arg764Cys p.Val1336Ile 20/800 +3.50 Clumped and bone-spicule pigment; macular pigmentary changes# 12 ND ND 4, 5, 7
P6 13/F p.Cys948Tyr p.Cys948Tyr 20/63 +4.75 Granular; PPRPE; macular pigmentary changes 7 ND <1
P7 13/M p.Cys948Tyr p.Gln335Pro 20/30 +5.25 Bone-spicule pigment; granular 87 ND 13
P8 18/F p.Arg764Cys p.Val1336Ile 20/63 +1.25 Bone-spicule pigment; white dots 30 ND 1 4, 5, 7, 45
P9 20/M p.Cys948Tyr p.Cys948Tyr 20/80 +1.00 Clumped pigment# 3 ND ND
P10 22/M p.Val578Glu p.Val578Glu 20/400 +4.50 Clumped pigment; macular pigmentary changes; white dots 4 ND 7 7
P11 25/F p.Cys948Tyr p.Cys948Tyr 20/200 +8.75 Clumped pigment; macular pigmentary changes 8 ND ND 7
P12 25/M p.Pro748 del3 p.Pro748 del3 20/125 +2.00 Clumped pigment; white and yellow dots 8 ND <1 4, 5, 7, 45
P13 26/M p.Arg764Cys p.Arg764Cys 20/40 +0.75 Bone-spicule pigment; white and yellow dots 35 ND 4
P14 26/F p.Ile852Thr p.Leu1097Arg LP +9.25 Clumped pigment; macular pigmentary changes ND ND ND
P15 27/F p.Gly477Arg p.Arg764Cys 20/300 +3.50 Clumped and bone-spicule pigment; macular pigmentary changes; white and yellow dots 45 ND 5
P16 27/M p.Val578Glu p.Val578Glu 20/1600** +6.75 Clumped pigment; macular pigmentary changes; white dots <1 ND <1 7
P17 29/F p.Cys85 ins2 p.Thr745Met 20/800 +5.25 Clumped pigment; macular pigmentary changes 20 ND 3 5, 7
P18 34/F p.Cys383Tyr p.Asn871 ins1 CF +6.25 Clumped pigment; macular atrophy 2 ND 2 4, 5
P19 38/M p.Cys948Tyr p.Trp1370Cys 20/70 +1.00 Bone-spicule pigment; white dots 61 ND 8
P20 44/M p.Cys948Tyr p.Cys587Tyr HM +7.00 Clumped pigment; macular pigmentary changes ND ND ND
P21 47/F p.Gly477Arg p.Arg764Cys 20/50 Pseudophakia Granular; clumped pigment 37 NP NP
P22 48/M p.Lys801X p.Leu1074Ser LP** Pseudophakia Bone-spicule pigment; macular atrophy# ND ND ND 5, 7

PPRPE, preserved para-arteriole retinal pigment epithelium; ND, not detectable; NP, not performed; F&FL, fixes and follows light; CF, counts fingers; HM, hand motion; LP, light perception.

*

Best corrected visual acuity (eye with better acuity).

Spherical equivalent.

All had vitreous cells, attenuated retinal vessels, and various degrees of waxy appearance of the optic nerve head.

§

Expressed as a percentage of normal mean of V-4e target; 2 SD below normal is 90%13; average both eyes; similar in the two eyes unless specified.

Expressed as a percentage of normal mean amplitude (rod = 292 μV; cone flicker = 172 μV); 2 SD below normal is 67% for rod b-wave and 60% for cone flicker.14

Indicates sibling pairs: P5 and P8, P10 and P16, P15 and P21.

#

Coats disease.

**

Keratoconus.

HHS Vulnerability Disclosure